These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24830435)

  • 21. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg].
    Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model.
    Bourgine M; Dion S; Godon O; Guillen G; Michel ML; Aguilar JC
    Virology; 2012 Aug; 430(1):10-9. PubMed ID: 22591777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of anti-HBV immune activity by DNA vaccine via electroporation using heat shock proteins as adjuvant.
    Xu Y; Wang Y; Zhao B; Zhang X; Fan H; Li X; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2013 Dec; 29(12):1765-75. PubMed ID: 24660624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep.
    Babiuk S; Tsang C; van Drunen Littel-van den Hurk S; Babiuk LA; Griebel PJ
    Bioelectrochemistry; 2007 May; 70(2):269-74. PubMed ID: 17118714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen.
    Shen M; Wang S; Ge G; Xing Y; Ma X; Huang Z; Lu S
    Vaccine; 2010 Oct; 28(45):7288-96. PubMed ID: 20831917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccination in utero: a new approach to induce protective immunity in the newborn.
    Gerdts V; Tsang C; Griebel PJ; Babiuk LA
    Vaccine; 2004 Apr; 22(13-14):1717-27. PubMed ID: 15068855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation.
    Kim CY; Kang ES; Kim SB; Kim HE; Choi JH; Lee DS; Im SJ; Yang SH; Sung YC; Kim BM; Kim BG
    Exp Mol Med; 2008 Dec; 40(6):669-76. PubMed ID: 19116452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.
    Kichaev G; Mendoza JM; Amante D; Smith TR; McCoy JR; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2013 Oct; 9(10):2041-8. PubMed ID: 23954979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HBV DNA vaccination with electroporation enhances significantly the specific cell-mediated immune response in mice against HBV protein vaccine consisting of S-PreS1 fusion particles].
    Chen H; Zhang LL; Tan WJ; Deng Y; Wang W; Yin X; Wen B; Guan J; Ruan L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Apr; 24(2):94-7. PubMed ID: 21110423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models.
    Draghia-Akli R; Khan AS; Brown PA; Pope MA; Wu L; Hirao L; Weiner DB
    Vaccine; 2008 Sep; 26(40):5230-7. PubMed ID: 18450333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization.
    Mancini M; Hadchouel M; Tiollais P; Michel ML
    J Immunol; 1998 Nov; 161(10):5564-70. PubMed ID: 9820533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation.
    Dolter KE; Evans CF; Ellefsen B; Song J; Boente-Carrera M; Vittorino R; Rosenberg TJ; Hannaman D; Vasan S
    Vaccine; 2011 Jan; 29(4):795-803. PubMed ID: 21094270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells.
    Wang J; Su B; Ding Z; Du X; Wang B
    Biochem Biophys Res Commun; 2008 Aug; 372(3):491-6. PubMed ID: 18502198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The study about immune response to Balb/c mice inoculated with hepatitis B virus DNA vaccine pCI/S2S].
    He X; Zhao LS; Zhou TY; He F; Jiang N
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):945-8. PubMed ID: 18095592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
    Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
    Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
    Zhou Z; Chen WS; Zhang HH; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant.
    Zhang L; Widera G; Rabussay D
    Bioelectrochemistry; 2004 Jun; 63(1-2):369-73. PubMed ID: 15110305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.